A Smartphone Application (QuitBot) for the Improvement of Smoking Cessation Among American Indians and Alaska Natives, NAITIVE Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFred Hutchinson Cancer Center

About this trial

This clinical trial develops a chatbot smartphone application (app), QuitBot, and text messaging to help American Indians (AI) and Alaska Natives (AN) to quit smoking commercial tobacco (smoking cessation), and evaluates two remote smoking cessation programs to see how well they work for helping AI/AN people quit smoking commercial tobacco. AI/AN populations have one of the highest rates of commercial cigarette smoking of any racial and ethnic group in the United States (US). They also have a higher rate of developing smoking-related cancer but are less likely to quit smoking. The two programs are designed to provide personalized support in setting a smoking cessation goal, tasks to reach the smoking cessation goal, and motivation to remain smoke-free. This may help to keep participants engaged and support them in their quit efforts, and may improve smoking cessation among AI and AN.

Eligibility criteria

Qualifiers

Self-identifying as American Indian or Alaska Native, either alone or in combination with other races

Age 18 and older

Smoking combustible cigarettes daily in the past year

Interest in quitting smoking

Disqualifiers

The reverse of the inclusion criteria

Pregnant or breastfeeding

Use of other tobacco products (e.g., ceremonial use of tobacco, e-cigarettes) will be assessed but is not an exclusion criterion, as it would limit the study's generalizability

Trial design

Treatments tested in this trial

  • QuitBot Smoking Cessation Chatbot Program
  • QuitBot Smoking Cessation Text Messaging Program
  • Survey Administration
  • Interview
  • Carbon Monoxide Measurement

Treatment groups

772 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Fred Hutchinson Cancer Center

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator